Dimensional Fund Advisors’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Dimensional Fund Advisors’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-239,874	Closed	-$4.79M	–	3560
2022 Q3	$4.79M	Buy	239,874 +147,946	+161%	+$1.95M	﹤0.01%	2439
2022 Q2	$633K	Sell	91,928 -29,767	-24%	-$209K	﹤0.01%	3017
2022 Q1	$1.13M	Buy	121,695 +7,859	+7%	+$83.7K	﹤0.01%	2965
2021 Q4	$1.62M	Buy	113,836 +60,984	+115%	+$1.06M	﹤0.01%	2903
2021 Q3	$1.23M	Buy	+52,852	New	+$1.25M	﹤0.01%	2997

Dimensional Fund Advisors's FMTX Position: Q4 2022 in Review

Dimensional Fund Advisors sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 239,874 shares — an estimated $4.79M sold.

Dimensional Fund Advisors first reported a position in FMTX in Q3 2021 and held it in 5 quarters. The position peaked at $4.79M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Dimensional Fund Advisors reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Dimensional Fund Advisors sold 239,874 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $4.79M.
Dimensional Fund Advisors first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
Dimensional Fund Advisors's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $4.79M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Dimensional Fund Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.